Remove tag quality-life
article thumbnail

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US

Pharmaceutical Technology

Currently, most patients face the prospect of life-long treatment with MS medications, as the main objectives of available disease-modifying therapies (DMTs) are to reduce the frequency of relapses and to delay the accumulation of disability. DMTs for MS have a high price tag, particularly in the US.

98
article thumbnail

The “Graziella Molinari Women in Pharma Award” Announced for 2022 Edition at the ISPE Italy Affiliate

ISPE

This important initiative was created to celebrate the commitment, perseverance, professionalism and competence of the women who work in this sector, qualities that accompanied and distinguished the work of Graziella Molinari, former Vice President of ISPE Italy and active partner for many years, from which the recognition itself takes its name.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. ICER uses quality-adjusted life year (QALY), a cost effectiveness metric to measure the value of a healthcare intervention.

FDA 59
article thumbnail

Blue Note leukaemia DTx gets FDA breakthrough tag

pharmaphorum

He is the principal investigator for a clinical study that will evaluate the impact of BNT200 on quality of life, mood, and symptoms of patients diagnosed with AML. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on. Other DTxs are aimed at people being treated for breast and lung cancers.

FDA 63
article thumbnail

5 Things I Love About The MAD-ID Conference, The Antimicrobial Stewardship Meeting

IDStewardship

It has claimed the tag line “The Antimicrobial Stewardship Meeting.” Generating Ideas from Poster Session Conversations This is not a conference with a huge quantity of research posters, but the quality of the work presented at MAD-ID is high. The high concentration of great minds and topics leads to a lot of good ideas.

article thumbnail

ASH: Argenx cues up a second use for efgartigimod

pharmaphorum

She told ASH that current therapies for ITP have limitations, including tolerability issues, lacklustre efficacy and a short duration of effect, as well as having a limited impact on quality of life.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.